Joana L. Mora

Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

Priscilla K. Brastianos, Eudocia Q. Lee, Justine V. Cohen et al. · Nature Medicine · 2020 · 157 citations

Medicine, Oncology, Pharmacology +10

Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas

Priscilla K. Brastianos, Albert E. Kim, Anita Giobbie‐Hurder et al. · Nature Communications · 2022 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases

Franziska M. Ippen, Julia Grosch, Megha Subramanian et al. · Neuro-Oncology · 2019 · 99 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis

Priscilla K. Brastianos, Matthew R. Strickland, Eudocia Q. Lee et al. · Nature Communications · 2021 · 91 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid

Michael White, Robert H. Klein, Brian Shaw et al. · JAMA Network Open · 2021 · 82 citations · Full text

Medicine, Oncology, Pathology +17